company background image
2395 logo

Shin Nippon Biomedical Laboratories TSE:2395 Stock Report

Last Price

JP¥1.41k

Market Cap

JP¥57.5b

7D

3.5%

1Y

-35.6%

Updated

12 Jun, 2024

Data

Company Financials +

Shin Nippon Biomedical Laboratories, Ltd.

TSE:2395 Stock Report

Market Cap: JP¥57.5b

2395 Stock Overview

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

2395 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance1/6
Financial Health3/6
Dividends3/6

Shin Nippon Biomedical Laboratories, Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shin Nippon Biomedical Laboratories
Historical stock prices
Current Share PriceJP¥1,408.00
52 Week HighJP¥2,465.00
52 Week LowJP¥1,286.00
Beta-0.011
1 Month Change-5.19%
3 Month Change-7.37%
1 Year Change-35.65%
3 Year Change67.42%
5 Year Change102.01%
Change since IPO-35.71%

Recent News & Updates

Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 21
Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 10
Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Recent updates

Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 21
Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 10
Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Mar 12
Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

Feb 27
Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

Shareholder Returns

2395JP Life SciencesJP Market
7D3.5%0.4%0.3%
1Y-35.6%-41.0%17.5%

Return vs Industry: 2395 exceeded the JP Life Sciences industry which returned -40.5% over the past year.

Return vs Market: 2395 underperformed the JP Market which returned 19.8% over the past year.

Price Volatility

Is 2395's price volatile compared to industry and market?
2395 volatility
2395 Average Weekly Movement5.1%
Life Sciences Industry Average Movement5.1%
Market Average Movement3.9%
10% most volatile stocks in JP Market7.5%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 2395 has not had significant price volatility in the past 3 months.

Volatility Over Time: 2395's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19571,341Ryoichi Nagatawww.snbl.co.jp

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies. The company also engages in the investigator brochure preparation support, clinical trial protocol creation support, clinical trial medical institution, investigational drug allocation, clinical trial request/contract, monitoring, quality management, data management, statistical analysis work, comprehensive report creation support, electronic application support, regulatory affairs consulting, and creating informed consent documents support services.

Shin Nippon Biomedical Laboratories, Ltd. Fundamentals Summary

How do Shin Nippon Biomedical Laboratories's earnings and revenue compare to its market cap?
2395 fundamental statistics
Market capJP¥57.49b
Earnings (TTM)JP¥5.53b
Revenue (TTM)JP¥26.45b

10.6x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2395 income statement (TTM)
RevenueJP¥26.45b
Cost of RevenueJP¥13.50b
Gross ProfitJP¥12.95b
Other ExpensesJP¥7.42b
EarningsJP¥5.53b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)132.86
Gross Margin48.96%
Net Profit Margin20.91%
Debt/Equity Ratio76.0%

How did 2395 perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

38%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.